Hubert Czerniak TV - Te BADANIA musi zrobić każdy! Skuteczna DIAGNOSTYKA stanu ZDROWIA

Czerniak opens with this as the ‘podstawa wszystkich badań’ — the foundation of all testing. He explicitly demands ‘rozmaz ręczny’ (manual smear) rather than an automated differential, because automated counters can miss atypical cells or misclassify monocytes and blasts. He adds the sedimentation rate (OB) using the classic Westergren method, CRP, iron, and ferritin (the garbled ‘kwercetyna’ almost certainly stands for ferrytyna). The combined picture allows a clinician to pick up hidden chronic infections, smoldering inflammation, and iron-deficient states before they become clinically obvious. By insisting on this manual, old-school approach, he signals his preference for quality over speed and his distrust of purely machine-driven diagnostics. In his view, skipping this panel means walking in the dark, regardless of what more sophisticated tests are ordered later.

Czerniak challenges the common practice of testing only TSH as a thyroid screen. He argues that the thyroid axis is dynamic, and you need a snapshot of all three hormones simultaneously. More provocatively, he warns that even when TSH, FT3, and FT4 are perfectly normal, the gland may already be under autoimmune attack — a phase that can last years before hormone levels finally derail. He explicitly lists the antibodies that must be checked: the garbled ‘any.tv’ is the spoken form of anti-TPO, and he adds anti-Tg and anti-TSH receptor antibodies. For him, omitting these antibodies means missing the window for early dietary or lifestyle intervention that could slow autoimmunity. This stance elevates thyroid autoantibody testing from a niche confirmatory test to a front-line screening tool for everyone.

Czerniak presents this panel as a practical metabolic safety net. He openly prefers the classic OGTT but acknowledges that patients find it burdensome and nauseating; hence his alternative: a normal, solid meal followed by a one-hour blood draw. He claims this single time-point of glucose and insulin gives deep insight into pancreatic reserve — the organ’s ability to handle a real meal. He does not stop at insulin resistance; he extends into autoimmunity, testing for anti-GAD, anti-IA2, and anti-islet cell antibodies to catch latent autoimmune diabetes in adults (LADA), which is often misdiagnosed as type 2 diabetes. The final pillar is homocysteine, a protein whose proper range he defines as 5–8 µmol/L. He explicitly warns that damage to the vessel lining begins at 10 µmol/L, regardless of what the lab report prints as the upper limit. By bundling these markers, he aims to simultaneously screen for pre-diabetes, autoimmune diabetes, and vascular risk in one visit.

Czerniak states bluntly that a large proportion of people have vitamin D in the single digits or low teens — levels at which every system is compromised. He is scathing about local laboratory norms that consider 30 ng/mL sufficient, contrasting this with Scandinavian countries where up to 200–250 ng/mL is accepted without alarm. He frames the gap not as scientific disagreement but as deliberate manipulation to keep individuals classified as sick and thus reliant on the healthcare system. His practical advice: do not even glance at the ‘normal’ column; aim for 70–100 ng/mL, a range he considers both safe and effective. He does not specify a supplementation protocol, implying that dose must be individualized based on blood levels. The overarching message is that vitamin D is non-negotiable and that current mainstream guidance keeps people deficient on purpose.

Czerniak’s liver protocol is concise but complete. He insists that if total bilirubin is elevated, it must be split into indirect and direct, because this single step narrows the differential dramatically. He does not elaborate on specific disease states, trusting that a physician will handle interpretation, but he makes it clear that no health screening is complete without looking at the liver. His inclusion of this panel alongside metabolic tests suggests he views liver stress as a silent accomplice in metabolic syndrome.

Czerniak teaches the audience how to collect urine correctly: reject the first stream that flushes out urethral contaminants, then catch the midstream. He cautions that finding bacteria without white blood cells usually means the sample was contaminated, not that there is a urinary tract infection. On the chemistry panel, he explains the clinical logic: if urea is high but creatinine is normal, the person is eating too much meat; if creatinine starts climbing, the kidneys are becoming insufficient. Uric acid, he warns, can announce gout long before the first agonizing attack. He describes the classic podagra (big toe), gonagra (knee), and chiragra (thumb), and adds that simply treating the pain with anti-inflammatories is not a cure — urate-lowering therapy is needed. This panel, in his hands, serves both a screening and an educational purpose, teaching patients to read their own lab results intelligently.

Czerniak’s message on PSA is a calming antidote to cancer panic. He acknowledges that PSA is a useful screening tool but stresses that an elevated value is not a synonym for cancer. Benign hyperplasia, prostatitis, and even a recent DRE or ejaculation can raise PSA. The missing piece, he argues, is the physical exam. He states bluntly: ‘the finger is the most important examination.’ A hard, firm prostate on DRE suggests a malignant process; a soft, exquisitely painful one suggests infection. This tactile information, available immediately and at no extra cost, anchors the interpretation of the lab number. He warns against the cascade of anxiety-driven biopsies and overtreatment that can occur when PSA is viewed in isolation, and reminds men that a thoughtful, sequential approach — number plus finger — is the only way to avoid ‘demonizing’ the test.

Czerniak uses this protocol to draw attention to a classic but often forgotten pediatric emergency. He describes the scenario where a child has painful, swollen knees that resolve completely, leaving no residual joint damage — yet the real tragedy unfolds silently in the heart, where the valves become scarred (rheumatic endocarditis). The diagnostic lynchpin is ASO, which proves recent streptococcal infection. He pairs it with rheumatoid factor or anti-CCP to screen for rheumatoid arthritis, and recommends hand and wrist X-rays. But his most forceful demand is that any doctor encountering such a patient must listen to the heart. He frames this not as a nice-to-have but as a mandatory step; if the doctor skips it, the patient should demand it, and if the doctor still refuses, it is sheer unwillingness. This segment is a rare blend of laboratory recommendation and patient empowerment, reminding the audience that clinical examination still saves lives.

Czerniak opens with the observation that many of his patients have vitamin D levels in the single digits or low teens (ng/mL). He notes that some Polish laboratories have recently raised their upper limit to 70 or even 100 ng/mL, but the typical lab still flags 30 ng/mL as sufficient. Abroad, especially in Scandinavia, norms reach 200–250 ng/mL — levels that Polish labs would consider toxic. He then draws a direct line to pharmaceutical strategy: if the 'normal' range is kept low, a huge portion of the population becomes medically 'deficient' and therefore eligible for chronic supplementation or, more importantly, for a cascade of other medications tied to low vitamin D. The same logic applies to homocysteine: a 'normal' up to 15 µmol/L ignores the fact that endothelium damage begins at concentrations as low as 10 µmol/L. He urges listeners to view lab printouts with deep skepticism and to remember that 'Poles, like pelicans, swallow everything TV commercials show them.' This is not a fringe nutritional opinion; he presents it as an explanation for why people stay sick despite being 'within range,' and why doctors continue to prescribe rather than cure.

Czerniak acknowledges that the gold standard is a full OGTT with samples at 0, 1, and 2 hours after ingesting 75 g of glucose, but he concedes that it is ‘trudne i niezbyt przyjemne’ (difficult and not very pleasant). His pragmatic hack: consume a good, solid meal and have blood drawn exactly one hour later for simultaneous glucose and insulin. He argues that this single pair of values tells you how the pancreas truly handles a real-world carbohydrate load, because fasting glucose alone stays normal long after post-meal insulin response has deteriorated. If you can only afford one metabolic test, the 1-hour post-meal draw is his clear preference. He extends the protocol by adding pancreatic antibodies (anti-GAD, anti-IA2, and anti-islet cell) to screen for autoimmune destruction, and homocysteine to assess vascular risk — creating a compact but powerful metabolic snapshot.

Czerniak states that if there is any suspicion of thyroid dysfunction, the full panel — TSH, FT3, FT4 — should be drawn at the same time to obtain a frozen-frame picture of the pituitary–thyroid axis. He then goes a step further: because it is possible for the gland to function normally in the face of an autoimmune attack, the absence of antibody testing leaves a diagnostic blind spot. He specifically names anti-TPO (any.tv, garbled), anti-Tg, and anti-TSH receptor antibodies (TRAb). In his view, this is not only for patients with overt goiter or symptoms; anyone undergoing a thorough health evaluation should include these antibodies to catch the earliest phase of autoimmune thyroiditis, which can be asymptomatic for years. This proactive approach, he implies, can avoid a later crisis when hormone levels finally crash or surge.

Czerniak recounts the classic scenario: a child develops painful, swollen knees that resolve completely, leaving no visible trace on the joints — yet the real sequelae occur in the heart, in the form of rheumatic endocarditis that scars the valves permanently. He insists that whenever a patient, especially a young one, comes with joint complaints, the doctor is obligated to auscultate the heart. He tells patients explicitly: if the doctor does not reach for the stethoscope, ask ‘a jak serce?’ (and what about the heart?). If the doctor refuses or ignores the request, it’s not because they lack knowledge, but because they simply don’t want to — a sign of professional laziness. This statement is both a consumer right and a diagnostic imperative.